Two-dimensional (2D) nanomaterials have been widely used
in biomedical
applications because of their biocompatibility. Considering the high
risk of exposure of the circulatory system to Ti3C2T
x
, we studied the cytocompatibility
of Ti3C2T
x
MXene
with red blood cells (RBCs) and human umbilical vein endothelial cells
(HUVECs) and showed that Ti3C2T
x
had excellent compatibility with the two cell lines.
Ti3C2T
x
at a concentration
as high as 200 μg/mL caused a negligible percent hemolysis of
0.8%. By contrast, at the same treatment concentration, graphene oxide
(GO) caused a high percent hemolysis of 50.8%. Scanning electron microscopy
revealed that RBC structures remained intact in the Ti3C2T
x
treatment group, whereas
those in the GO group completely deformed, sunk, and shrunk, which
resulted in the release of cell contents. This difference can be largely
ascribed to the distinct surficial properties of the two nanosheets.
In specific, the fully covered surface-terminating −O and −OH
groups leading to Ti3C2T
x
had a very hydrophilic surface, thereby hindering its penetration
into the highly hydrophobic interior of the cell membrane. However,
the strong direct van der Waals attractions coordinated with hydrophobic
interactions between the unoxidized regions of GO and the lipid hydrophobic
tails can still damage the integrity of the cell membranes. In addition,
the sharp and keen-edged corners of GO may also facilitate its relatively
strong cell membrane damage effects than Ti3C2T
x
. Thus, the excellent cell membrane
compatibility of Ti3C2T
x
nanosheets and their ultraweak capacity to provoke excessive ROS
generation endowed them with much better compatibility with HUVECs
than GO nanosheets. These results indicate that Ti3C2T
x
has much better cytocompatibility
than GO and provide a valuable reference for the future biomedical
applications of Ti3C2T
x
.